Related Experiment Video
Updated: May 4, 2026

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury
Published on: July 27, 2014
TGF-β-induced fibrotic scar formation limits recovery of spinal cord injury
Dayu Pan1, Panfeng Wu1, Kathleen Noller1,2
1Departments of Orthopedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abstract:
Spinal cord injury (SCI) often causes long-term disability. But effective means to promote proper regeneration after SCI has so far failed to reach the clinic. Here, we report that fibrotic scar formation at injury sites prevents recovery after SCI and that the inhibition of fibrotic scar formation significantly improved SCI recovery in adult mice. We found that after SCI there is an elevation of macrophages, which are a primary source of activated transforming growth factor-β 1 (TGF-β1) that in turn recruits mesenchymal stromal/stem cells (MSCs) to induce their fibroblast differentiation, thus promoting scar formation. We also found that activated TGF-β1 acts on resident pericytes in the endothelial niche of the blood-spinal cord barrier to promote their differentiation into fibroblasts, which also contributes to scarring. Interrupting these pathways by selective genetic KOs or treatment with a TGF-β-neutralizing antibody inhibited scar formation and improved SCI functional recovery. Notably, we found that neonatal mice recover scarlessly after SCI and with no active TGF-β at the injury site. Together, these findings suggest that fibrotic scarring occurs due to elevated activation of TGF-β, and preventing such activation or neutralizing active TGF-β may be an approach to improve outcome after SCI.
Insights
Inhibiting fibrotic scar formation after spinal cord injury (SCI) significantly improved recovery in mice. Blocking transforming growth factor-beta (TGF-β) activation or neutralizing TGF-β reduced scarring and enhanced functional outcomes.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Immunology
Background:
- Spinal cord injury (SCI) leads to long-term disability due to limited regeneration.
- Fibrotic scar formation at the injury site impedes functional recovery after SCI.
Purpose of the Study:
- To investigate the role of fibrotic scar formation in SCI recovery.
- To identify molecular pathways driving scar formation after SCI.
- To evaluate therapeutic strategies targeting scar formation for SCI treatment.
Main Methods:
- Investigated macrophage and mesenchymal stromal/stem cell (MSC) interactions post-SCI in mice.
- Examined the role of transforming growth factor-beta 1 (TGF-β1) in scar development.
- Utilized genetic knockouts (KOs) and TGF-β-neutralizing antibodies to inhibit scar formation.
- Compared SCI recovery in adult and neonatal mice.
Main Results:
- Elevated macrophages after SCI produce TGF-β1, promoting MSC differentiation into fibroblasts and scar formation.
- Activated TGF-β1 also induces pericyte differentiation into fibroblasts, contributing to scarring.
- Inhibition of TGF-β1 pathways via genetic KOs or antibody treatment reduced scarring and improved functional recovery in adult mice.
- Neonatal mice exhibited scarless recovery with minimal active TGF-β at the injury site.
Conclusions:
- Fibrotic scarring after SCI is driven by elevated TGF-β activation.
- Targeting TGF-β activation or neutralizing TGF-β presents a promising therapeutic strategy for improving SCI outcomes.
- Understanding scar formation mechanisms is crucial for developing effective SCI regeneration therapies.
Related Concept Videos
TGF - β Signaling Pathway
Healing II: Complications
Spinal Cord Injury ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology

